cont'd............
Symbol Company # of Reports Quarter Release Time
CYTK Cytokinetics Inc 12 quarters Q1 After
BKUNA BankUnited Financial April earnings Q4 Before
UFI Unifi, Inc. 12 quarters Q3 Before
HTBK Heritage Commerce Corp 6 quarters Q1 After
KTEC Key Technology Inc 12 quarters Q2 After
TESS Tessco Technologies Inc April earnings Q4 After
Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event. because the information is so vital to the market's perception of the vitality of that company.
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
Cytokinetics, Incorporated (CYTK), a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule drug therapeutics for the treatment of cardiovascular diseases and cancer. The company's lead product includes CK-1827452, a cardiac muscle myosin activator, which is in Phase IIa clinical trials for the treatment of heart failure. Its products under development stage comprise Ispinesib, a kinesin spindle protein inhibitor that is in Phase I/II clinical trials for the treatment of metastatic breast cancer; SB-743921, which is in Phase I/II trials to treat patients with non-Hodgkin or Hodgkin lymphoma; and GSK-923295, centromere-associated protein E inhibitor, which is in Phase I clinical trials to treat patients with refractory solid tumors. The company's products under preclinical stage consist of CK-2017357, a skeletal sarcomere activator for the treatment of diseases and conditions associated with muscle weakness or wasting; and smooth muscle myosin inhibitor for the treatment of pulmonary arterial hypertension, and diseases and medical conditions associated with bronchoconstriction. It has a strategic alliance with Amgen Inc. to discover, develop, and commercialize novel small-molecule therapeutics that activate cardiac muscle contractility for applications in the treatment of heart failure, as well as with GlaxoSmithKline to develop GSK-923295. The company was founded in 1997 and is headquartered in South San Francisco, California.
BankUnited Financial Corporation (BKUNA) operates as the holding company for BankUnited, FSB that provides consumer and commercial banking products and services to consumers and businesses located primarily in Florida. It offers various deposit products, including personal and commercial transaction accounts, money market accounts, other savings accounts, and time deposits. The company's lending activities comprise one-to-four-family residential mortgage loans, including residential mortgages and specialty consumer mortgages; consumer loans consisting of home equity loans, lines of credit, and automobile, boat, and cash collateral loans; commercial real estate loans and multi-family loans; real estate construction loans; land loans; secured and unsecured commercial business loans; and investments and mortgage-backed securities. It also offers investment, retirement planning, insurance, and financial planning services. In addition, the company offers automated teller machines, telebanking, and Internet banking services. As of November 12, 2007, it operated 86 branches, 2 loan production offices, and 7 offices outside of Florida. The company was founded in 1984 and is headquartered in Coral Gables, Florida.
Market Data 
Markets 
